Roivant Sciences (ROIV) Gross Margin Growth (3y) (2023 - 2026)
Roivant Sciences (ROIV) Gross Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 193,280.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 589.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 6.06 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 53.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 569.00 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -21.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.00 |
| Dec 31, 2025 | 960.00 |
| Sep 30, 2025 | 2,199.00 |
| Jun 30, 2025 | 3,287.00 |
| Dec 31, 2024 | 1,518.00 |
| Sep 30, 2024 | 4,039.00 |
| Jun 30, 2024 | 693.00 |
| Dec 31, 2023 | 597.00 |
| Sep 30, 2023 | 4,793.00 |
| Jun 30, 2023 | -807.00 |